Enhancing retention and efficacy of cardiosphere-derived cells administered after myocardial infarction using a hyaluronan-gelatin hydrogel.

Accordingly, while changes in scar mass mirrored changes in infarct size, viable tissue mass increased in CDC-treated patients (+13.0 ± 11.4 g at 6 mo), but not in controls (+0.9 ± 6.2 g at 6 mo), and the correlation between scar shrinkage and increased viability was highly significant (r = -0.59, p = 0.0007).

also in 132,142 other papers